EMAIL THIS PAGE TO A FRIEND

Pediatrics

Methsuximide for intractable childhood seizures.


PMID 1987529

Abstract

Methsuximide was added to the therapeutic regimens of 25 children with intractable epilepsy. In 15 patients the drug was well tolerated and resulted in a 50% or greater reduction in seizure frequency. No serious or irreversible adverse effects were seen. Methsuximide is frequently overlooked and may be an effective adjunctive antiepileptic for children with intractable seizures.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

860581
α-Methyl-α-phenylsuccinimide, 99%
C11H11NO2